| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8934703 | British Journal of Anaesthesia | 2012 | 8 Pages |
Abstract
Our findings suggest that demethylating tumour-suppressive effects of anaesthetic interventions may only be detectable in specific types of cancer due to differential methylation profiles. In conclusion, at clinically relevant concentrations, lidocaine demethylates DNA of breast cancer cell lines in vitro.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
P. Lirk, R. Berger, M.W. Hollmann, H. Fiegl,